MAPK3 and neoplasm: CXCL1/2 also promoted the expression of paracrine factor S100A9, activated ERK1/2 and p70S60k, and promoted tumor growth, while blocking CXCL1/2 down-regulated the expression of these pro-survival factors and slowed tumor growth.